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CASE PRESENTATION
A 44-year-old Caucasian female presented to the
ophthalmologist with blurry vision and excessive tearing
in the right eye. She was diagnosed with iritis and treated
with steroid eye drops. Soon after, the patient went to her
primary care physician with complaints of fevers, chills,
fatigue, and anorexia. The patient was found to have a
serum creatinine of 1.7 mg/dl (normal 0.5–1.2 mg/dl),
which increased to 1.9 mg/dl over the following 4 weeks,
at which time she was referred for nephrologic evaluation.
At the time of nephrologic consultation, physical
examination revealed a well-appearing but obese woman
with a height of 66 inches, weight 228 lbs, and blood
pressure of 122/80 mm Hg. There was trace to 1þ
bilateral lower extremity edema. Her physical exam was
otherwise unremarkable. Specifically, she had no oral
lesions, lymphadenopathy, skin rash, joint swelling, or
cardiac murmur or rub.
Other than the recent iritis, the patient had no
significant past medical history. She took no prescription
medications, and she denied use of herbal medications
and non-steroidal anti-inflammatory drugs. There were no
recent intravenous contrast studies. She denied oral
lesions, joint aches or swelling, rashes, shortness of breath,
focal weakness, abdominal pain, diarrhea, or chest pain.
Initial laboratory evaluation revealed a sodium of
139 mmol/l (135–146 mmol/l), potassium 3.1 mmol/l
(3.5–5.3 mmol/l), chloride 108 mmol/l (98–110 mmol/l),
serum bicarbonate 19 mmol/l (21–33 mmol/l), blood urea
nitrogen 22 mg/dl (7–22 mg/dl), serum creatinine 2.2 mg/
dl (0.5–1.2 mg/dl), serum calcium 10 mg/dl (8.5–10.4 mg/
dl), serum albumin 4.0 g/dl (3.5–4.9 g/dl), and cholesterol
171 mg/dl (normal o200 mg/dl). Liver function tests were
unremarkable with the exception of a mildly elevated
alkaline phosphatase of 139 U/l (20–125 U/l). Urinalysis
showed 1þ blood and 1þ protein with 10–20
white blood cells/high-power field. No white blood cell or
red blood cell casts were seen. Negative serologies
included anti-nuclear antibody, anti-double stranded DNA
antibody, anti-glomerular basement membrane antibody,
proteinase-3 anti-neutrophil cytoplasmic antibodies,
myeloperoxidase anti-neutrophil cytoplasmic antibodies,
hepatitis B surface antigen, and hepatitis C antibody. C3
and C4 serum complement levels were mildly elevated at
193 mg/dl (90–180 mg/dl) and 69 mg/dl (16–47 mg/dl),
respectively. C-reactive protein was also elevated at
1.6 mg/dl (less than 0.8 mg/dl). Serum and urine
immunofixation did not reveal a monoclonal spike.
Twenty-four-hour urine collection revealed 1.5 g of
protein. Chest X-ray was normal, without evidence of hilar
adenopathy or infiltrates. The kidneys measured 11.2 and
12.9 cm in length by ultrasound. The patient had a white
blood cell count of 11.0 (3.8–10.8 103/ml), which was
composed of 70% neutrophils (nl 38–80%), 16%
lymphocytes (nl 15–49%), 9% monocytes (nl 0–13%), and
3.5% eosinophils (nl 0–8%). Her hematocrit was 33.6%
(35–45%). Two weeks later, a repeat blood test showed a
rise in serum creatinine to 2.4 mg/dl. A percutaneous renal
biopsy was then performed.
RENAL BIOPSY FINDINGS
Sampling for light microscopy consisted of a single core of
renal cortex containing six glomeruli, all of which appeared
histologically unremarkable. The predominant abnormalities
involved the tubulointerstitial compartment. There was
moderate diffuse interstitial inflammation composed of
mainly lymphocytes, with rare monocytes and eosinophils
(Figure 1). No interstitial granulomas were identified. The
interstitial inflammation extended across tubular basement
membranes to produce extensive tubulitis. Proximal tubules
displayed mild resultant degenerative changes. There was no
significant tubular atrophy or interstitial fibrosis. There was
minimal intimal sclerosis of an artery, but no evidence of
vasculitis.
Sampling for immunofluorescence consisted of eight
glomeruli. Immunofluorescence staining for IgG, IgM, IgA,
C3, C1, k- and l-light chains, fibrinogen, and albumin was
negative. Electron microscopy confirmed the absence of
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glomerular, tubulointerstitial, or vessel wall deposits. Visceral
epithelial cells exhibited 20% foot process effacement. No
endothelial tubuloreticular inclusions were found.
INITIAL DIAGNOSIS
Acute interstitial nephritis (associated with anterior uveitis).
Clinical follow-up
Following receipt of the renal biopsy results, the patient was
started on oral prednisone at 60 mg daily. One week after
initiating treatment, her creatinine improved to 1.6 mg/dl but
her liver function tests increased to an aspartate amino-
transferase of 47 U/l (3–35 U/l) and an alanine aminotrans-
ferase of 89 U/l (3–40 U/l). Repeat hepatitis serologies were
negative. After 4 weeks of therapy her liver function tests
normalized. After 3 months of prednisone 60 mg/day, her
serum creatinine declined to 1.2 mg/dl. Prednisone was
slowly tapered and her serum creatinine remained stable.
She continues to complain of eye irritation periodically, and
is being treated by her ophthalmologist with steroid eye
drops. She has remained off of oral prednisone for the past 2
months, with a stable serum creatinine of 1.2 mg/dl. During
the period of follow-up the patient has had no evidence of
xerophthalmia, xerostomia, subcutaneous or hilar lymph-
adenopathy, pulmonary dysfunction, cutaneous disease,
hypercalcemia, or other potential manifestation of Sjogren
syndrome or Sarcoidosis. In light of the clinical and
pathologic findings, the patient was diagnosed with tubu-
lointerstitial nephritis with uveitis (TINU).
Final diagnosis
Tubulointerstitial nephritis with uveitis.
DISCUSSION
Acute interstitial nephritis (AIN) is a histologic pattern
of renal injury associated with acute renal failure, sterile
pyuria, and low-grade proteinuria. Pathologic findings
include interstitial inflammation, tubulitis, and tubular
degenerative changes. Multiple diverse, unrelated conditions
are associated with AIN. The most common etiology is
allergic/drug-induced disease, which most often follows
treatment with antibiotics, non-steroidal anti-inflammatory
drugs, diuretics, anti-convulsants, or proton pump inhibi-
tors. Allergic/drug-induced AIN is commonly accompanied
by systemic signs of a hypersensitivity reaction including
fever, rash, and eosinophilia.1 AIN also may occur as a
manifestation of autoimmune/collagen vascular disease
such as systemic lupus erythematosus, Sjogren syndrome,
or mixed connective tissue disease. AIN may represent
renal involvement by sarcoidosis or may be the result
of fungal, viral, or bacterial infection of the renal parench-
yma. There are multiple additional, uncommon conditions
associated with AIN, and some cases are idiopathic. In
a recent review of 128 cases of AIN, the etiology was drug
induced in 71.1% of cases, infection associated in 15.6% of
cases, idiopathic in 7.8%, and TINU syndrome in 4.7% of
patients.2
TINU syndrome was first described as a distinct entity by
Dobrin et al.3 in 1975. Uveitis is defined as inflammation in
the middle vascular layer of the eye, the uvea. Anterior uveitis
is generally limited to inflammation of the iris. Intermediate
uveitis includes inflammation of the ciliary body and
vitreous. Posterior uveitis includes retinitis and choroiditis.
Since 1975, approximately 140 additional cases have been
reported. A review by Mandeville et al.4 looked at 133 cases of
TINU in the literature and found a female predominance (3:1
female to male ratio) and a median age of 15 years (range of
9–74 years). Risk factors for AIN were investigated in 122 of
the 133 cases, and in approximately half of the cases, no risk
factor was identified. Preceding antibiotic or non-steroidal
anti-inflammatory drug use was reported in 24 and 18% of
TINU patients, respectively.
a b
Figure 1 | Pathologic findings. (a) A renal biopsy shows interstitial inflammation composed of mainly lymphocytes. The interstitial
inflammation extends across tubular basement membranes to produce tubulitis. A normocellular glomerulus is seen in the upper right corner
of the field (Hematoxylin and eosin (H&E), original magnification  400). (b) Another field with prominent interstitial inflammation and
tubulitis. The arrows denote the smaller, darker nuclei of lymphocytes, which contrast with the larger, paler nuclei of tubular epithelial cells
(H&E, original magnification  400).
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The two cases of TINU first described by Dobrin were in
teenage girls, age 14 and 17, who presented with acute renal
failure due to eosinophilic interstitial nephritis. Both had
bilateral anterior uveitis and bone marrow granulomas.2
In subsequent reports, the most common presenting signs
and symptoms were fever, weight loss, fatigue, malaise, eye
pain or redness, anorexia, weakness/asthenia, abdominal or
flank pain, arthralgias or myalgias, polyuria, and headache.3
Laboratory findings include renal insufficiency in 90% of
patients (defined as serum creatinine 41.2 mg/dl), low-grade
proteinuria in 86%, leukocyturia in 55%, microhematuria in
42%, and normoglycemic glycosuria in 47%.4 Urinary b-2
microglobulin was elevated in all of the 34 cases that were
tested. Urinary eosinophils are seen in only 3% of cases.4 Of
the 133 TINU patients reviewed by Mandeville, ocular
symptoms preceded AIN in 21% of cases, were concurrent
in 15%, and followed AIN by up to 14 months in the
remaining 65% of cases. Owing to the asynchronous
development of uveitis and renal or systemic manifestations,
TINU is likely to be an underdiagnosed entity.
The pathogenesis of TINU is poorly understood. A
disturbance in cell-mediated immunity is supported by
studies showing a predominance of T lymphocytes in the
renal interstitium,5 lymphokine abnormalities,6 abnormal
T-cell ratios,7,8 and the dramatic response of renal disease to
corticosteroids. A genetic predisposition is raised by a report
of TINU in two monozygotic twin boys.9 Importantly,
Levinson et al.10 performed HLA typing for class 1 and class 2
genes on 18 patients with TINU and found a strong
association with certain HLA-DQ and HLA-DR alleles. In
particular, the HLA-DRB1*0102 allele confers a relative risk
for TINU syndrome of 167.1 (95% confidence interval
50.1–629.7).
Humoral immunity may also play a role in the develop-
ment of TINU. Hypergammaglobulinemia is common in
patients with TINU. A single case of TINU has been reported
in which there was anti-tubular basement membrane
antibodies, and disappearance of the antibodies coincided
with resolution of renal dysfunction.11 These findings raise
the possibility of an antibody with cross-reactivity for an
antigen present in both tubular epithelia and the uvea. Of
note, the absence of significant immunofluorescence staining
for immunoglobulins in the majority of renal biopsies argues
against a prominent role for humoral immunity in TINU.
The potential role of infection as a trigger for the immune
reaction has been proposed as an etiology for TINU. While
individual cases of Chlamydia12 and EBV13 infection in
patients with TINU have been reported, no series or clusters
of cases have been linked to an infectious process.
There are multiple disease entities other than TINU that
are associated with tubulointerstitial nephritis and uveitis,
most notably sarcoidosis and Sjogren syndrome. Both of
these diseases may be difficult to distinguish from TINU. In
the case reported herein, the absence of pulmonary
symptoms, hilar adenopathy, or hypercalcemia argues against
sarcoidosis. Testing for angiotensin-converting enzyme levels,
which are commonly elevated in sarcoidosis, was not
performed. Furthermore, TINU is far more common in
Caucasian patients while sarcoidosis is mainly seen in
patients of African-American descent.
Sjogren syndrome also appears unlikely given the absence
of xerophthalmia or xerostomia, the negative anti-nuclear
antibody, and the patient’s young age. Furthermore, the
ocular symptoms of eye pain and redness in Sjogren
syndrome are typically due to dry eye rather than uveitis.
Other conditions that are rarely associated with interstitial
nephritis and uveitis and that also were excluded in this
patient include systemic lupus erythematosis and Behcet
disease. There was no clinical suspicion of tuberculosis or
toxoplasmosis. In light of these considerations, TINU should
be regarded as a diagnosis of exclusion.14
The pathology of TINU is similar to other forms of
interstitial nephritis and is characterized by interstitial
inflammation and tubulitis. The predominant cell type
within the interstitium is lymphocytes. Interstitial eosino-
phils are reported in one-third of cases, neutrophils are seen
in 25% of biopsies, and non-caseating granulomas are
observed in 13% of renal biopsy specimens. Tubules show
infiltrating mononuclear cells and acute tubular injury, often
most severe in proximal tubules. Immunofluorescence
studies are generally negative in glomeruli and tubular
basement membranes.4
Due to the low incidence of TINU, prospective rando-
mized trials investigating treatment have not been performed.
In many cases, the syndrome resolves spontaneously or after
discontinuation of possible inciting drugs. In the review by
Mandeville, 99 of the 133 patients (80%) received systemic
corticosteroids for uveitis that was unresponsive to topical
steroids or for renal dysfunction.4 Outcomes for the uveitis
were provided, and recurrences were seen in 41% of
patients.4 In contrast, the interstitial nephritis tended to be
more responsive to therapy and was less frequently associated
with disease relapses. In a series of 10 patients with TINU
who were followed for 16–94 months, all patients recovered
normal renal function within 1 year. Systemic steroids were
administered to 7 of the 10 patients because of chronic or
severe uveitis that was unresponsive to topical cortico-
steroids. The authors concluded that systemic steroids are
generally not required for the renal manifestations of TINU.5
While corticosteroids are the mainstay of treatment for both
the ocular and, when necessary, renal manifestations of
TINU, immunomodulatory agents including methotrexate15,
cyclosporine16, azathioprine15, and mycophenolate mofetil17
have been used successfully in cases that were not responsive
to steroids.
In summary, TINU is distinct clinical-pathologic entity
that is most commonly seen in young women. The diagnosis
of TINU requires exclusion of other conditions that are
associated with interstitial nephritis and ocular symptoms,
mainly sarcoidosis and Sjogren syndrome. The renal
manifestations of TINU often resolve spontaneously and
respond well to systemic corticosteroids. While the renal
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disease is usually self-limited, the uveitis often has a chronic
or relapsing course that requires more aggressive therapy.
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